Supporting this hypothesis, a decline of EGR3 expression has been shown to decrease motility of non-small cell lung cancer cells39, while EGR3 has been associated with migration and invasion in hepatocellular40,41 and breast carcinomas21. The gene discussed is EGR3; the disease is non-small cell lung carcinoma.